FOR IMMEDIATE RELEASE
13 February 2013
Announcing the keynotes of 6th Annual BioPharma Asia Convention 2013
Innovation is key to establishing sustainable pipelines and nurturing growth in the pharma industry. Discover core strategies for fostering growth and establishing optimal pharmaceutical innovation models as you learn from our keynotes. Speaking at 6th Annual Biopharma Asia Convention 2013, Asian and global leadership forum- Rebuilding the pharma business model to achieve sustainability and greater R&D efficiency are:
- Joaquin Duato, Worldwide Chairman Pharmaceuticals, Johnson & Johnson, USA
- Murtaza Khorakiwala, CEO & Managing Director, Wockhardt, India
- Nikhil Puri, Vice President, Worldwide Business Development, Pfizer, USA
About our keynotes
Joaquin Duato is Worldwide Chairman, Pharmaceuticals, Johnson & Johnson, a position he assumed in January 2011. He is responsible for the Company's global pharmaceutical commercial businesses, and the Operations, Quality, and Compliance functional groups that support the commercial and research and development organizations. He leads the Company's Pharmaceuticals Group Operating Committee.
Currently, Dr. Murtaza Khorakiwala is the Managing Director of Wockhardt Limited. Prior to this he was the Executive Director of Wockhardt Limited. He headed the Biotechnology and Active Pharmaceutical Ingredients (API) Business. Dr. Khorakiwala also provides leadership to the Biotechnology and Drug Discovery Research Programmes at Wockhardt. He plays an active role in new business developmental initiatives of the company. Prior to this he was a Head of Strategic Business Unit at Wallis Laboratories UK, which was Wockhardt's first trans-national acquisition.
Nikhil Puri is Vice President, Worldwide Business Development at Pfizer. He is responsible for the Company's business development initiatives for the Emerging Markets, and its global off-patent business (Established Products), a role he has held since early 2011. Business Development at Pfizer encompasses a wide range of strategic transactions ranging from product licensing to strategic alliances and joint ventures, and mergers and acquisitions.
For more detailed information about the event, please visit: www.terrapinn.com/biopharma
There are limited press passes available and press registration for the convention is compulsory. Advanced scheduling for interviews with speakers is recommended. Contact Jolene Lee at email@example.com to register for a press pass.
BioPharma Asia Convention is the largest biopharmaceutical event in Asia where 4000+ global and Asian biotech and pharmaceutical stakeholders come together to discuss issues, strategies, innovations and partnerships across the industry. Over 4 days with 7 different conferences tracks on partnering, stem cells, drug discovery, biologic manufacturing, sustainable manufacturing, clinical trials and supply chain, industry leaders and key decision makers from across the globe come together in Singapore for discussions and networking opportunities to determine the trends and strategies for the year ahead.
Name: Jolene Lee
Position: Marketing Manager, Terrapinn, Singapore
Contact number: +65 6322 2318
URL: www.terrapinn.com/biopharma | Blog: http://blogs.terrapinn.com/biopharma